Vol. 92, Issue 3, 1357-1362, March 2002
HIGHLIGHTED TOPICS
Functional Genomics of Sleep and Circadian
Rhythm
Selected Contribution: Circadian rhythm of
tumor necrosis factor-
uptake into mouse spinal cord
Weihong
Pan1,
Germaine
Cornélissen2,
Franz
Halberg2, and
Abba J.
Kastin1
1 Department of Medicine, Tulane University and the Veterans
Affairs Medical Center, New Orleans, Louisiana 70112-1262; and
2 Chronobiology Laboratories, University of Minnesota,
Minneapolis, Minnesota 55455
 |
ABSTRACT |
Circadian variations in the
actions of tumor necrosis factor-
(TNF-
) have been observed.
Because a saturable transport system at the blood-brain barrier
mediates most of the influx of TNF-
from blood to the central
nervous system (CNS), the circadian variation of the CNS effects of
TNF-
could be related to changes in this transport system.
Accordingly, we measured the uptake of intravenously injected TNF-
into various CNS regions at different times and compared these
measurements with the uptake into a peripheral control (muscle). We
found that the spinal cord, but not the brain, showed a circadian
rhythm in the uptake of TNF-
. This pattern is similar to that of
leptin but different from that of interleukin-1. The circadian rhythm
of the influx of TNF-
into this region of the CNS suggests a
functional role for the spinal cord in the physiological actions of
TNF-
.
blood-brain barrier; cytokine; transport
 |
INTRODUCTION |
THE CYTOKINE TUMOR
NECROSIS factor-
(TNF-
) is an important mediator of
communication between the central nervous system and the periphery.
Elevated blood concentrations of TNF-
, such as those that occur in
inflammation and various cancers, are related to sickness behavior, and
exogenous TNF-
can induce sleep. Specifically, TNF-
given
intraperitoneally in rats just before the onset of the dark phase
increases the time of non-rapid eye movement sleep in a dose-dependent
manner (11). TNF-
also attenuates fast waves and
enhances slow waves (11). Vagotomy attenuates
TNF-
-induced non-rapid eye movement sleep and abolishes
-activity
slowing, suggesting that vagal afferents mediate part of the
action (12). However, persistence of the somnogenic effect
of TNF-
suggests that other mediators are also present. TNF-
p55
receptor knockout mice fail to sleep more after the administration of
TNF-
, indicating that the p55 receptor is also essential for the
somnogenic effects (6).
In normal mice, basal endogenous TNF-
levels are below the limit of
detection under physiological conditions (19, 21). However, in humans, TNF-
concentrations show a biphasic elevation, peaking at 0730 and 1330 h, a pattern different from that of
interleukin-2, interleukin-10, and granulocyte-macrophage
colony-stimulating factor (23). The soluble p75 TNF-
receptor also shows a circadian rhythm with a peak around 0750 h,
preceding the peak of cortisol (13). By contrast, in
cancer patients, the concentration of TNF-
reaches its peak at
midnight (3). The circadian rhythm pattern of
TNF-
concentrations is likely related to the circadian variations in
the chemotherapeutic response to TNF-
. The toxic effect of a lethal
dose of TNF-
and survival probability appear to follow circadian
dynamics (10).
Circadian variation of the TNF-
mRNA concentration in brain has been
reported. There are regional differences, with the hypothalamus and
hippocampus having TNF-
expression higher in the light phase than in
the dark phase (4). Similarly, the concentration of TNF-
is highest in the hypothalamus, hippocampus, and cerebral cortex of the rat at the onset of light (7). This is
consistent with the onset of sleep in rats in the light phase.
Thus both peripheral and central sources of TNF-
could contribute to
sleep. To discern the importance of each individual source, it is
essential to evaluate the involvement of the blood-brain barrier (BBB)
in the uptake of TNF-
. Our laboratory has shown that TNF-
crosses
the BBB by a saturable transport system and that the p55 and p75
receptors are involved in this transport (9, 19). The BBB
would provide the most direct and immediate means for a cytokine such
as TNF-
to affect cortical activity because of its large surface
area of 100-150 cm2/g of brain, in contrast to the
much smaller area of the circumventricular organs of ~0.02
cm2/g of brain (22). A circadian rhythm at the
BBB is present for the nonapeptide
sleep-inducing peptide, which
has its highest entry from blood to brain between 1200 and 1600 h
(clock time, lights on 0600 h and lights off 1800 h)
(2), and for another somnogenic cytokine,
interleukin-1
, which has its highest influx at 0800 h and
lowest at 2400 h (1). Therefore, in this study, we
assessed whether there is circadian variation in the permeability of
the BBB to TNF-
. We measured the uptake of radiolabeled TNF-
by
brain and spinal cord and compared it with that of a peripheral control (muscle).
 |
MATERIALS AND METHODS |
Recombinant murine TNF-
(R&D Systems, Minneapolis, MN) was
radiolabeled with 125I by the chloramine-T method, the
reaction being stopped at 1 min, and the 125I-labeled
TNF-
was purified on a column of Sephadex G-10. The specific
activity of 125I-TNF-
was 80 Ci/g. Adult male CD1 mice
(Charles River), weighing 19-21 g at arrival, were housed at the
institutional animal care facility for 6 wk before study. The mice were
kept under a 12:12-h light-dark cycle (lights on at 0600 h, lights
off at 1800 h), with constant room temperature, water, and food.
Each group of mice was transferred from the animal room to the
procedure room immediately before their time of study and anesthetized
intraperitoneally with 40% urethane.
The groups were studied every 3 h (n = 5 mice/group, grouping = clock time). Mice were tested at clock
times 0300, 0600, 0900, 1200, 1500, 1800, 2100, and 2400 h within
a 24-h period by the same experimenter. Each mouse received 0.9 µCi
of 125I-TNF-
injected into the left jugular vein in 100 µl of lactated Ringer solution containing 1% bovine serum albumin.
At 10 min after this intravenous bolus injection of
125I-TNF-
, arterial blood was collected by transection
of the right common carotid artery, and the mouse was decapitated
immediately afterward. Blood was centrifuged to obtain serum. The whole
brain, without pineal and pituitary glands, and spinal cord segments (cervical, thoracic, and lumbar regions) were collected. Part of the
right gluteus major muscle was also collected as the peripheral control. The radioactivities of 125I-TNF-
in the weighed
tissue and in 50 µl of serum were measured in a gamma counter. The
uptake of 125I-TNF-
in blood and tissue was previously
shown by HPLC at 10 min to mainly represent intact TNF-
(9).
The ratios of tissue uptake of 125I-TNF-
at 10 min were
calculated for the brain-to-serum ratio, the spinal cord-to-serum
ratio, and the muscle-to-serum ratio and were expressed as microliters per gram [(cpm/g of tissue)/(cpm/µl of serum), where cpm is
counts/min]. The circadian rhythm of tissue uptake was evaluated by
cosinor methods. Because the circadian variation of the uptake of
TNF-
in a region did not appear to be sinusoidal, a
multiple-component model, including harmonic terms, in addition to the
24-h fundamental component, was used. Several cosine curves in harmonic
relation (24, 12, and/or 8 h) thus were fitted concomitantly.
Parameter tests at a trial period of 24 h were also performed to
compare TNF-
uptake at different sites. The rhythms were
characterized by the following parameters: 1) the midline
estimating statistic of rhythm (MESOR), a rhythm-adjusted mean;
2) for each cosine component, the double amplitude, a
measure of the extent of predictable change within a cycle; and
3) the acrophase, a measure of the timing of overall high
values recurring in each cycle.
 |
RESULTS |
There was no statistically significant circadian rhythm of
125I-TNF-
in serum [y = 56.2 + 5.0 cos(2
t/24
3.51), percent rhythm (PR) = 12%, P = 0.088], where t is time.
The PR is equivalent to R2 and is the proportion
of the variance (around the mean value), which is accounted for by the
fit of the model. Similarly, there was no statistically significant
circadian variation in the muscle uptake of 125I-TNF-
after intravenous delivery (Fig. 1), and
there was no significant circadian rhythm of 125I-TNF-
entry into the brain (Fig. 2). In
contrast, a statistically significant circadian rhythm was present for
the uptake of TNF-
into the spinal cord with a model that included
cosine curves with periods of 24 and 12 h (Fig.
3).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 1.
Lack of significant circadian variation of tumor necrosis
factor- (TNF- ) uptake by the muscle. Each point (mean ± SE)
represents mice studied at that particular clock time
(n = 5/group). The dashed curve was generated by the
fitted model. PR, percent rhythm; t, time. Lights
were on from 0600 to 1800 h (open bar). Hatched bar, lights off.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Lack of significant circadian variation of TNF- uptake by the
brain. The dashed curve was generated by the fitted model. Lights were
on from 0600 to 1800 h (open bar). Hatched bar, lights off.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Fig. 3.
Significant circadian rhythm of TNF- uptake by the total spinal
cord. The dashed curve was generated by the fitted model. Lights were
on from 0600 to 1800 h (open bar). Hatched bar, lights off.
|
|
A circadian rhythm was also demonstrated for each spinal cord
segment considered separately. Except for a statistically significant lower MESOR of the thoracic spinal cord (Table
1), overall the circadian
amplitude and acrophase were very similar among the spinal regions.
The peak 125I-TNF-
uptake occurred around 0456 h in the cervical spinal cord (Fig.
4), around 0324 h in the thoracic
spinal cord (Fig. 5), and around
0228 h in the lumbar spinal cord (Fig.
6).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Significant circadian rhythm of TNF- uptake by the cervical
spinal cord. The dashed curve was generated by the fitted model. Lights
were on from 0600 to 1800 h (open bar). Hatched bar,
lights off. The peak 125I-labeled TNF- uptake occurred
at 0456 h.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 5.
Significant circadian rhythm of TNF- uptake by the thoracic
spinal cord. The dashed curve was generated by the fitted model. Lights
were on from 0600 to 1800 h (open bar). Hatched bar, lights off.
The peak 125I-TNF- uptake occurred at 0324 h.
|
|

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 6.
Significant circadian rhythm of TNF- uptake by the lumbar spinal
cord. The dashed curve was generated by the fitted model. Lights were
on from 0600 to 1800 h (open bar). Hatched bar, lights off. The
peak 125I-TNF- uptake occurred at 0228 h.
|
|
There was no statistically significant circadian rhythm in the uptake
of TNF-
by the brain or muscle. Parameter tests comparing the brain
and spinal cord showed that the MESOR of the brain was larger than that
for thoracic, lumbar, or total spinal cord (P < 0.001)
but did not differ from that of the cervical spinal cord.
When the data were expressed as a percentage of each series mean value
to counteract the large difference in MESOR among muscle, serum, and
the central nervous system regions (i.e., MESOR = 100%), the
relative amplitudes and acrophases could be compared directly across
all regions in the test of equality of amplitudes and of the
amplitude-acrophase pairs. Analyses showed that the brain had a
circadian amplitude significantly smaller than that of any of the
spinal cord regions, whereas no intraregional difference was found in
the spinal cord. The difference in the amplitude-acrophase pair with
respect to brain is a further validation of the absence of a circadian
rhythm in the brain and the presence of a circadian rhythm in the
spinal cord. Only a numerical estimate of amplitude for brain could be
referred to, as the rhythm could not be detected. The control tissue,
muscle, had no statistically significant circadian rhythm.
 |
DISCUSSION |
Accumulating evidence suggests that circulating TNF-
participates in sleep regulation. The variations of plasma TNF-
concentrations in certain human subjects seem to assume a similar
pattern with the amplitude of electroencephalographic
-wave
frequency (5). Reciprocal interactions of TNF-
and
melatonin have also been observed, suggesting that TNF-
stimulates
melatonin secretion, whereas melatonin in turn inhibits TNF-
release
into blood (14). One would expect a circadian variation in
the availability of TNF-
to the brain by penetration of the BBB. On
the contrary, we found no statistically significant circadian rhythm of
TNF-
uptake by the brain. However, a circadian rhythm of TNF-
uptake by the spinal cord was detected.
The circadian variations in the uptake of 125I-TNF-
into
the spinal cord could not be described by a simple sinusoidal
relationship. Several cosine curves in harmonic relation were fitted
concomitantly, and the zero-amplitude assumption was tested for each of
the components included in the model. Basically, the presence of
harmonic terms in the model expresses the departure of the rhythmic
waveform from a pure sine curve. In addition, a P value is
provided for the model as a whole, which is an F test
comparing the variability accounted for by the composite model with the
residual variation. A significant rhythm was present in the total
spinal cord as well as its individual segments. The reasons for the
seemingly multiphasic responses, however, are unclear. Perhaps the
secondary peaks seem more apparent because of the short duration of the
main peak around 0200-0300 h. Nevertheless, despite the
statistical differences in acrophase and recurrent time among cervical,
thoracic, and lumbar segments, parameter tests at a trial period of
24 h (two-way ANOVA) did not show a statistically significant
difference among the spinal cord regions.
The presence of a circadian rhythm for the BBB permeability of TNF-
in the spinal cord but not in the brain also occurs for leptin, an
ingestive polypeptide similar in size to TNF-
that is produced in
the periphery but exerts its potent satiety signal in the brain. In the
spinal cord of the mouse, the influx rate of leptin peaks around
2400 h and reaches its nadir around 0800 h (17).
Yet the blood concentration of leptin is high enough under normal
physiological conditions to account for partial saturation of the
saturable transport system in the brain. In contrast, TNF-
is
usually not detectable in the blood of normal mice and thus should not
have saturated the transport system for TNF-
at the BBB. The lack of
circadian rhythm of TNF-
uptake in the brain indicates that
alternative pathways of access (e.g., diffusion to the hypothalamus by
circumventricular organs and vagal nerve afferents) may explain the
peripheral effects of TNF-
on the electroencephalogram.
A regional difference in the BBB permeation of TNF-
is present in
mice, with the spinal cord having a higher influx than the brain
(15). This differential permeability also is apparent in
p55 or p75 receptor knockout mice, which have a significantly decreased
uptake in the spinal cord but not in the brain (19). The
blood-spinal cord barrier also is more susceptible to regulatory processes such as spinal cord injury (18, 20) and
experimental autoimmune encephalomyelitis (16), in which
the transport system for TNF-
is upregulated. Thus the presence of a
circadian rhythm for TNF-
adds to the unique features of the
endothelial blood-spinal cord barrier.
 |
ACKNOWLEDGEMENTS |
This work was supported by National Institute of Alcohol Abuse and
Alcholism Grant AA-12865, National Institute of Diabetes and Digestive
and Kidney Diseases Grant DK-54880, Office of Naval Research Grant
N00014-01-1-0343, and the Department of Veterans Affairs.
 |
FOOTNOTES |
Address for reprint requests and other correspondence: W. Pan,
8F 159, VAMC, 1601 Perdido St., New Orleans, LA 70112-1262 (E-mail:
wpan{at}tulane.edu).
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
10.1152/japplphysiol.00915.2001
Received 4 September 2001; accepted in final form 21 November 2001.
 |
REFERENCES |
1.
Banks, WA,
Kastin AJ,
and
Ehrensing CA.
Diurnal uptake of circulating interleukin-1
by brain, spinal cord, testis and muscle.
Neuroimmunomodulation
5:
36-41,
1998[ISI][Medline].
2.
Banks, WA,
Kastin AJ,
and
Selznick JK.
Modulation of immunoactive levels of DSIP and blood-brain permeability by lighting and diurnal rhythm.
J Neurosci Res
14:
347-355,
1985[ISI][Medline].
3.
Baranowski, M,
Muc-Wierzgon M,
Madej K,
Wierzgon J,
and
Zubelewicz B.
The estimation of endogenous tumor necrosis factor alpha and cortisol levels in serum in advanced neoplasm.
J Exp Clin Cancer Res
18:
241-245,
1999[ISI][Medline].
4.
Bredow, S,
Guha-Thakurta N,
Taishi P,
Obal F, Jr,
and
Krueger JM.
Diurnal variations of tumor necrosis factor
mRNA and
-tubulin mRNA in rat brain.
Neuroimmunomodulation
4:
84-90,
1997[ISI][Medline].
5.
Darko, DF,
Miller JC,
Gallen C,
White J,
Koziol J,
Brown SJ,
Hayduk R,
Atkinson JH,
Assmus J,
Munnell DT,
Naitoh P,
McCutchan JA,
and
Mitler MM.
Sleep electroencephalogram delta-frequency amplitude, night plasma levels of tumor necrosis factor
, and human immunodeficiency virus infection.
Proc Natl Acad Sci USA
92:
12080-12084,
1995[Abstract/Free Full Text].
6.
Fang, J,
Wang Y,
and
Krueger JM.
Mice lacking the TNF 55 kDa receptor fail to sleep more after TNF
treatment.
J Neurosci
17:
5949-5955,
1997[Abstract/Free Full Text].
7.
Floyd, RA,
and
Krueger JM.
Diurnal variation of TNF alpha in the rat brain.
Neuroreport
8:
915-918,
1997[ISI][Medline].
8.
Glabinski, AR,
and
Ransohoff RM.
Chemokines and chemokine receptors in CNS pathology.
J Neurovirol
5:
3-12,
1999[ISI][Medline].
9.
Gutierrez, EG,
Banks WA,
and
Kastin AJ.
Murine tumor necrosis factor alpha is transported from blood to brain in the mouse.
J Neuroimmunol
47:
169-176,
1993[ISI][Medline].
10.
Hrushesky, WJ,
Langevin T,
Kim YJ,
and
Wood PA.
Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality.
J Exp Med
180:
1059-1065,
1994[Abstract/Free Full Text].
11.
Krueger, JM,
Fang J,
Taishi P,
Chen Z,
Kushikata T,
and
Gardi J.
Sleep. A physiologic role for IL-1
and TNF-
.
Ann NY Acad Sci
856:
148-159,
1998[Abstract/Free Full Text].
12.
Kubota, T,
Fang J,
Guan Z,
Brown RA,
and
Krueger JM.
Vagotomy attenuates tumor necrosis factor-
-induced sleep and EEG
-activity in rats.
Am J Physiol Regulatory Integrative Comp Physiol
280:
R1213-R1220,
2001[Abstract/Free Full Text].
13.
Liebmann, PM,
Reibnegger G,
Lehofer M,
Moser M,
Purstner P,
Mangge H,
and
Schauenstein K.
Circadian rhythm of the soluble p75 tumor necrosis factor (sTNF-R75) receptor in humans
a possible explanation for the circadian kinetics of TNF-
effects.
Int Immunol
10:
1393-1396,
1998[Abstract/Free Full Text].
14.
Lissoni, P,
Barni S,
Tancini G,
Brivio F,
Tisi E,
Zubelewicz B,
and
Braczkowski R.
Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-
and the pineal hormone melatonin.
J Biol Regul Homeost Agents
8:
126-129,
1994[ISI][Medline].
15.
Pan, W,
Banks WA,
and
Kastin AJ.
Permeability of the blood-brain and blood-spinal cord barriers to interferons.
J Neuroimmunol
76:
105-111,
1997[ISI][Medline].
16.
Pan, W,
Banks WA,
Kennedy MK,
Gutierrez EG,
and
Kastin AJ.
Differential permeability of the BBB in acute EAE: enhanced transport of TNF-
.
Am J Physiol Endocrinol Metab
271:
E636-E642,
1996[Abstract/Free Full Text].
17.
Pan, W,
and
Kastin AJ.
Diurnal variation of leptin entry from blood to brain involving partial saturation of the transport system.
Life Sci
68:
2705-2714,
2001[ISI][Medline].
18.
Pan, W,
and
Kastin AJ.
Increase in TNF
transport after SCI is specific for time, region, and type of lesion.
Exp Neurol
170:
357-363,
2001[ISI][Medline].
19.
Pan W and Kastin AJ. TNF
transport across the blood-brain
barrier is abolished in receptor knockout mice. Exp Neurol
In press.
20.
Pan, W,
Kastin AJ,
Bell RL,
and
Olson RD.
Upregulation of tumor necrosis factor
transport across the blood-brain barrier after acute compressive spinal cord injury.
J Neurosci
19:
3649-3655,
1999[Abstract/Free Full Text].
21.
Peschon, JJ,
Torrance DS,
Stocking KL,
Glaccum MB,
Otten C,
Willis CR,
Charrier K,
Morrissey PJ,
Ware CB,
and
Mohler KM.
TNF receptor-deficient mice reveal divergent roles for p55 and p75 in several models of inflammation.
J Immunol
160:
943-952,
1998[Abstract/Free Full Text].
22.
Strand, FL.
Neuropeptides: Regulators of Physiological Processes. Cambridge, MA: MIT Press, 1999, p. 89.
23.
Young, MR,
Matthews JP,
Kanabrocki EL,
Sothern RB,
Roitman-Johnson B,
and
Scheving LE.
Circadian rhythmometry of serum interleukin-2, interleukin-10, tumor necrosis factor-
, and granulocyte-macrophage colony-stimulating factor in men.
Chronobiol Int
12:
19-27,
1995[ISI][Medline].
J APPL PHYSIOL 92(3):1357-1362